What is Lumiata?
Headquartered in San Mateo, California, Lumiata operates at the intersection of advanced machine learning and healthcare administration. The company provides a sophisticated database platform that integrates millions of patient records with clinical, risk, and financial algorithms. By offering pre-trained models and analytic tools, Lumiata enables healthcare organizations to move beyond reactive care models toward proactive, predictive strategies. Its market position is defined by its ability to synthesize disparate data sources into actionable intelligence, thereby helping stakeholders manage healthcare costs and improve patient outcomes in an increasingly complex regulatory and economic environment.
How much funding has Lumiata raised?
Lumiata has raised a total of $22.4M across 4 funding rounds:
Series A
$5M
Debt
$3M
Debt
$350K
Series B
$14M
Series A (2014): $5M with participation from BlueCross BlueShield Venture Partners, L.P., Sandbox Industries, and AmeriHealth
Debt (2017): $3M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Series B (2021): $14M featuring Defy.vc, AllegisNL Capital, Khosla Ventures, and The Blue Venture Fund
Key Investors in Lumiata
BlueCross BlueShield Venture Partners, L.P.
A venture capital firm managing over $500 million, specializing in strategic investments that align with the priorities of Blue Cross and Blue Shield plans.
Sandbox Industries
A venture capital firm focused on the intersection of entrepreneurial innovation and large-scale corporate enterprises, with a strong emphasis on the healthcare sector.
Khosla Ventures
A prominent venture firm providing strategic advice and capital to breakthrough technology companies, with a deep focus on AI, enterprise software, and health tech.
What's next for Lumiata?
With the recent influx of capital, Lumiata is well-positioned to scale its enterprise-level operations and expand its suite of predictive tools. The strategic focus will likely center on deepening the integration of its AI models within existing payer and provider workflows, ensuring that clinical decision support remains both accurate and scalable. As the healthcare industry continues to prioritize value-based care, Lumiata's ability to provide granular risk assessment and cost-management solutions will be pivotal. Future growth will likely involve enhancing the platform's interoperability and expanding its footprint across diverse healthcare ecosystems, solidifying its role as a foundational technology partner for organizations navigating the digital transformation of medical services.
See full Lumiata company page
